Wetenschappelijke publicaties van Erasme

Wetenschappelijke publicaties van Erasme

  • A plain language summary of the CheckMate 9DW study: nivolumab in combination with ipilimumab for unresectable hepatocellular carcinoma (advanced liver cancer).

  • Auteurs Yau T, Galle PR, Decaens T, Sangro B, Qin S, da Fonseca LG, Karachiwala H, Blanc JF, Park JW, Gane E, Pinter M, Matilla Peña A, Ikeda M, Tai D, Santoro A, Pizarro G, Chiu CF, Schenker M, He A, Chon HJ, Wojcik-Tomaszewska J, Verset G, Wang QQ, Stromko C, Neely J, Singh P, Jimenez Exposito MJ, Kudo M
  • Revue Future Oncol
  • Date de publication 2026-04
A plain language summary of the CheckMate 9DW study: nivolumab in combination with ipilimumab for unresectable hepatocellular carcinoma (advanced liver cancer).
  • Spectrum and significance of 18F-FDG-PET/CT abnormalities in VEXAS syndrome.

  • Auteurs Betrains A, Jachiet V, Dieudonné Y, Dion J, Lazaro E, Jean A, de Moreuil C, Ardois S, Grosleron S, Arlet JB, Durel CA, Delaval L, Papo T, Herbin Cavaro AC, Vinzio S, Martis N, Bouillet L, Audia S, Nicolas B, Golden C, Langlois V, Perlat A, Vandergheynst F, Decker P, Moulinet T, Lacombe V, Samson M, Blockmans D, Kosmider O, Georgin-Lavialle S, Mekinian A, Terrier B
  • Revue Rheumatology (Oxford)
  • Date de publication 2026-04
Spectrum and significance of 18F-FDG-PET/CT abnormalities in VEXAS syndrome.
  • Tafamidis in women with wild-type transthyretin cardiac amyloidosis: an international cohort study.

  • Auteurs Debonnaire P, L'Hoyes W, Dujardin K, Donal E, Verheyen N, Dupont M, De Sutter J, Timmermans P, Pouleur AC, Droogmans S, Issa VS, Dulgheru R, Regeer M, Jurcut R, Bondue A, Bohyn A, Bogaerts K, Christiaen E, Wyseure N, Bezard M, Zach D, Schwegel N, Knapen R, Buytaert L, de Marneffe N, Ajmone Marsan N, Adam R, Tavernier R, Buysschaert I, Trenson S
  • Revue Eur Heart J Qual Care Clin Outcomes
  • Date de publication 2026-04
Tafamidis in women with wild-type transthyretin cardiac amyloidosis: an international cohort study.
  • Correction: Comprehensive analysis of CNOT3-related neurodevelopmental disorders: phenotypic and genotypic characterization.

  • Auteurs Engel C, Rendek M, Assoumani J, Argilli E, Ariani F, Avice-Denizet AL, Bijlsma EK, Blanc P, Bruno LP, Callewaert B, Capra V, Carullo M, Chesneau B, Coppens S, Curry C, Dale B, Dahlen E, Delahaye-Duriez A, Denommé-Pichon AS, Demeer B, Dvořáková L, Fischer J, Geneviève D, Giacomini T, Handrup MM, Heron D, Hüning I, Iacomino M, Isidor B, Keren B, Kmoch S, Koolen DA, Kübler A, Laštůvková J, Le C, Levy J, Rizzo CL, Maitz S, Marlin S, Mignot C, Mirzaa G, Nagel I, Neuens S, Nosková L, Pao E, Pecková A, Plaisancie J, Porrmann J, Privitera F, Reis A, Renieri A, Rio M, Rippert A, Ryba L, Scala M, Schieving JH, Sherr EH, Shuen A, Sidlow R, Smol T, Soblet J, Striano P, Suri M, Syryn H, Tran Mau-Them F, Travessa AM, Van Gils J, Vasileiou G, Verseput JJA, Vilain C, Vincent-Delorme C, Vyhnálková E, Wakeling EL, Zacher P, Zara F, Kuentz P, Piard J
  • Revue Eur J Hum Genet
  • Date de publication 2026-04
Correction: Comprehensive analysis of CNOT3-related neurodevelopmental disorders: phenotypic and genotypic characterization.
Huderf hospital

Queen Fabiola Kinderziekenhuis

Bekijk alle wetenschappelijke publicaties van het Koningin Fabiola Kinderziekenhuis

Bordet hospital

Jules Bordet-instituut

Bekijk alle wetenschappelijke publicaties van Jules Bordet

Decorative image of doctor and patient

Alle wetenschappelijke publicaties van het H.U.B.

Bekijk alle wetenschappelijke publicaties van het H.U.B.